Critical Care Glucose Point-of-Care Testing.
暂无分享,去创建一个
S. N. Narla | K. Hermayer | Yusheng Zhu | S N Narla | M Jones | K L Hermayer | Y Zhu | M. Jones | Y. Zhu | Satya Nandana Narla
[1] D. Bruns,et al. Analytic Evaluation of a New Glucose Meter System in 15 Different Critical Care Settings , 2013, Journal of diabetes science and technology.
[2] Huiying Li,et al. Adipocyte Fatty Acid-binding Protein Modulates Inflammatory Responses in Macrophages through a Positive Feedback Loop Involving c-Jun NH2-terminal Kinases and Activator Protein-1* , 2010, The Journal of Biological Chemistry.
[3] Joseph Wang,et al. Glucose Biosensors : 40 Years of Advances and Challenges , 2001 .
[4] O. Siggaard‐Andersen,et al. Direct reading glucose electrodes detect the molality of glucose in plasma and whole blood. , 1990, Clinica chimica acta; international journal of clinical chemistry.
[5] Irl B Hirsch,et al. Management of diabetes and hyperglycemia in hospitals. , 2004, Diabetes care.
[6] J. Mahoney,et al. Glucose Measurement: Confounding Issues in Setting Targets for Inpatient Management , 2007, Diabetes Care.
[7] Katsuhiko Kuwa,et al. Approved IFCC recommendation on reporting results for blood glucose (abbreviated). , 2005, Clinical chemistry.
[8] G J Kost,et al. Oxygen effects on glucose measurements with a reference analyzer and three handheld meters. , 2000, Diabetes technology & therapeutics.
[9] Joan Lee Parkes,et al. Accuracy Evaluation of Five Blood Glucose Monitoring Systems: The North American Comparator Trial , 2013, Journal of diabetes science and technology.
[10] P Schläpfer,et al. Electrochemical measurement of glucose using various electron acceptors. , 1974, Clinica chimica acta; international journal of clinical chemistry.
[11] H. Wahl. How accurately do we measure blood glucose levels in intensive care unit (ICU) patients? , 2009, Best practice & research. Clinical anaesthesiology.
[12] M. Furuhashi,et al. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. , 2008, The Journal of clinical investigation.
[13] S. ReddyVR,et al. Comparison of Point of Care (POC) Testing of Glucose by B Braun Glucometer and Hemocue Glucose 201+ Analyser Versus Centralised Testing in Neonatal Intensive Care Unit (NICU). , 2014 .
[14] Maryclare Prasnikar,et al. Comparison of point-of-care and laboratory glucose analysis in critically ill patients. , 2007, American journal of critical care : an official publication, American Association of Critical-Care Nurses.
[15] Yen-Wen Wu,et al. Serum adipocyte fatty acid-binding protein levels in patients with critical illness are associated with insulin resistance and predict mortality , 2013, Critical Care.
[16] James H Nichols,et al. Blood Glucose Testing in the Hospital: Error Sources and Risk Management , 2011, Journal of diabetes science and technology.
[17] G. Cembrowski,et al. Accuracy of glycemic measurements in the critically ill. , 2008, Diabetes technology & therapeutics.
[18] B. Wisse,et al. Point‐of‐care blood glucose measurement errors overestimate hypoglycaemia rates in critically ill patients , 2015, Diabetes/metabolism research and reviews.
[19] Thomas G Schleis,et al. Interference of Maltose, Icodextrin, Galactose, or Xylose with Some Blood Glucose Monitoring Systems , 2007, Pharmacotherapy.
[20] C. Price. Point-of-Care Testing in Diabetes Mellitus , 2003, Clinical chemistry and laboratory medicine.
[21] A. Keeling,et al. Dopamine Influence on Whole-Blood Glucose Reagent Strips , 1987, Diabetes Care.
[22] H. Krumholz,et al. Glucometrics in Patients Hospitalized With Acute Myocardial Infarction: Defining the Optimal Outcomes-Based Measure of Risk , 2008, Circulation.
[23] C. Jimeno,et al. Accuracy of Point-of-Care Blood Glucose Measurements in Critically Ill Patients in Shock , 2014, Journal of diabetes science and technology.
[24] R. Cohen,et al. Pseudohypoglycemia: a cause for unreliable finger-stick glucose measurements. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[25] R. Bellomo,et al. Glycemic control in the ICU. , 2011, Chest.
[26] Ralph A. DeFronzo,et al. From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus , 2009, Diabetes.
[27] O. Fourcade,et al. Relative accuracy of arterial and capillary glucose meter measurements in critically ill patients. , 2012, Diabetes & metabolism.
[28] Joyce Y. Wu,et al. Can one point-of-care glucose meter be used for all pediatric and adult hospital patients? Evaluation of three meters, including recently modified test strips. , 2011, Diabetes technology & therapeutics.
[29] Eun-Hyung Yoo,et al. Glucose Biosensors: An Overview of Use in Clinical Practice , 2010, Sensors.
[30] Mario Plebani,et al. Post-analytical errors with portable glucose meters in the hospital setting. , 2009, Clinica chimica acta; international journal of clinical chemistry.
[31] G. V. Berghe,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[32] A. Turner,et al. Quinoprotein glucose dehydrogenase and its application in an amperometric glucose sensor. , 1986, Biosensors.
[33] James Stephen Krinsley,et al. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. , 2003, Mayo Clinic proceedings.
[34] P. Cryer. The Barrier of Hypoglycemia in Diabetes , 2008, Diabetes.
[35] W Janssen,et al. Positive interference of icodextrin metabolites in some enzymatic glucose methods. , 1998, Clinical chemistry.
[36] B. Kavanagh,et al. Clinical practice. Glycemic control in the ICU. , 2010, The New England journal of medicine.
[37] J. Kulys,et al. Pyrroloquinoline quinone-dependent carbohydrate dehydrogenase: activity enhancement and the role of artificial electron acceptors. , 2010, Biotechnology journal.
[38] K. Wiener. An Assessment of the Effect of Haematocrit on the Hemocue Blood Glucose Analyser , 1993, Annals of clinical biochemistry.
[39] K. Tamama,et al. Discrepant Glucose Results between Capillary and Venous Blood in an 83-Year-Old White Man. , 2014, Laboratory medicine.
[40] Ksenia Tonyushkina,et al. Glucose Meters: A Review of Technical Challenges to Obtaining Accurate Results , 2009, Journal of diabetes science and technology.
[41] Brian Hutton,et al. Reliability of point-of-care testing for glucose measurement in critically ill adults* , 2005, Critical care medicine.
[42] G J Kost,et al. Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. , 2000, American journal of clinical pathology.
[43] S. Efendić. Pathogenesis of NIDDM. , 1988, Diabetes research and clinical practice.
[44] A. Hoofnagle,et al. Measuring point-of-care blood glucose in critically ill patients , 2015 .
[45] M. Kosiborod,et al. Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit , 2014, BMJ Open Diabetes Research and Care.
[46] M. J. Rice,et al. Challenges to Glycemic Measurement in the Perioperative and Critically Ill Patient: A Review , 2009, Journal of diabetes science and technology.
[47] J. Preiser,et al. Year in review 2013: Critical Care - metabolism , 2014, Critical Care.
[48] B. Karon,et al. Evaluation of the Impact of Hematocrit and Other Interference on the Accuracy of Hospital-Based Glucose Meters , 2008 .
[49] Pier Giorgio Zambonin,et al. Ascorbic acid interferences in hydrogen peroxide detecting biosensors based on electrochemically immobilized enzymes , 1993 .
[50] Ahmad Haidar,et al. Accuracy of subcutaneous continuous glucose monitoring in critically ill adults: improved sensor performance with enhanced calibrations. , 2014, Diabetes technology & therapeutics.
[51] P. Cryer,et al. Insulin Reciprocally Regulates Glucagon Secretion in Humans , 2010, Diabetes.
[52] W. Zijlstra,et al. Absorption spectra of human fetal and adult oxyhemoglobin, de-oxyhemoglobin, carboxyhemoglobin, and methemoglobin. , 1991, Clinical chemistry.
[53] S. Kos,et al. Validation of a new generation POCT glucose device with emphasis on aspects important for glycemic control in the hospital care , 2012, Clinical chemistry and laboratory medicine.
[54] G J Kost,et al. Oxygen effects on glucose meter measurements with glucose dehydrogenase- and oxidase-based test strips for point-of-care testing , 2001, Critical care medicine.
[55] J. Sloand,et al. Avoidable Iatrogenic Hypoglycemia in Patients on Peritoneal Dialysis: The Risks of Nonspecific Glucose Monitoring Devices and Drug-Device Interaction , 2014, Journal of patient safety.
[56] Frederick L. Kiechle,et al. Blood Glucose: Measurement in the Point-of-Care Setting , 2000 .
[57] I Gibb,et al. HemoCue: evaluation of a portable photometric system for determining glucose in whole blood. , 1992, Clinical chemistry.
[58] W Zingg,et al. Clinical Control of Diabetes by the Artificial Pancreas , 1974, Diabetes.
[59] J. Preiser,et al. International recommendations for glucose control in adult non diabetic critically ill patients , 2010, Critical care.
[60] A. Heller,et al. Electrochemical Glucose Sensors and Their Applications in Diabetes Management , 2008 .
[61] C. Scurlock,et al. Critique of normoglycemia in intensive care evaluation: survival using glucose algorithm regulation (NICE-SUGAR) – a review of recent literature , 2010, Current opinion in clinical nutrition and metabolic care.
[62] A. Kitabchi,et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. , 2002, The Journal of clinical endocrinology and metabolism.
[63] Jos J A M Weusten,et al. Is there a suitable point-of-care glucose meter for tight glycemic control? Evaluation of one home-use and four hospital-use meters in an intensive care unit , 2012, Clinical chemistry and laboratory medicine.
[64] Joseph Wang,et al. Electrochemical Glucose Biosensors , 2008 .
[65] G J Kost,et al. Effects of pH on glucose measurements with handheld glucose meters and a portable glucose analyzer for point-of-care testing. , 2000, Archives of pathology & laboratory medicine.
[66] R. Epstein,et al. Intraoperative Accuracy of a Point-of-Care Glucose Meter Compared with Simultaneous Central Laboratory Measurements , 2012, Journal of diabetes science and technology.
[67] Andrea Mosca,et al. Comparative Performance Assessment of Point-of-Care Testing Devices for Measuring Glucose and Ketones at the Patient Bedside , 2014, Journal of diabetes science and technology.
[68] N J Perera,et al. The danger of using inappropriate point‐of‐care glucose meters in patients on icodextrin dialysis , 2011, Diabetic medicine : a journal of the British Diabetic Association.
[69] P. Watkinson,et al. The effects of precision, haematocrit, pH and oxygen tension on point-of-care glucose measurement in critically ill patients: a prospective study , 2012, Annals of clinical biochemistry.
[70] Joris R Delanghe,et al. Analytical Interferences in Point-of-Care Testing Glucometers by Icodextrin and its Metabolites: An Overview , 2009, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[71] S. Tam,et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. , 2006, Clinical chemistry.
[72] O. Tanner. Intensive versus Conventional Glucose Control in Critically Ill Patients , 2009 .
[73] J. Winkelman,et al. Accuracy evaluation of a new glucometer with automated hematocrit measurement and correction. , 2005, Clinica chimica acta; international journal of clinical chemistry.
[74] S. Clarke,et al. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus , 2012, British journal of biomedical science.
[75] G J Kost,et al. Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing. , 2009, Archives of pathology & laboratory medicine.
[76] Z. Zaman,et al. Effect of non-glucose sugars and haematocrit on glucose measurements with Roche Accu-Chek Performa glucose strips , 2010, Annals of clinical biochemistry.
[77] A J M Boulton,et al. Blood glucose overestimation in diabetic patients on continuous ambulatory peritoneal dialysis for end‐stage renal disease , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[78] M. Lindh,et al. Electrochemical interferences with the YSI glucose analyzer. , 1982, Clinical chemistry.
[79] M. Ohtsuka,et al. Influence of blood sample oxygen tension on blood glucose concentration measured using an enzyme-electrode method. , 1997, Critical care medicine.
[80] B. Karon,et al. Evaluation of the impact of hematocrit and other interference on the accuracy of hospital-based glucose meters. , 2008, Diabetes technology & therapeutics.
[81] Ebtisam Wilkins,et al. Effect of interference on amperometric glucose biosensors with cellulose acetate membranes , 1994 .
[82] M. Fleisher,et al. Multicenter study of whole-blood creatinine, total carbon dioxide content, and chemistry profiling for laboratory and point-of-care testing in critical care in the United States , 2000, Critical care medicine.
[83] J. Joseph. Analysis: New Point-of-Care Blood Glucose Monitoring System for the Hospital Demonstrates Satisfactory Analytical Accuracy Using Blood from Critically Ill Patients—An Important Step toward Improved Blood Glucose Control in the Hospital , 2013, Journal of diabetes science and technology.
[84] J. Hoekstra,et al. The effect of diabetes mellitus on the association between measures of glycaemic control and ICU mortality: a retrospective cohort study , 2013, Critical Care.
[85] Sudha Reddy V R,et al. Comparison of Point of Care (POC) Testing of Glucose by B Braun Glucometer and Hemocue Glucose 201+ Analyser Versus Centralised Testing in Neonatal Intensive Care Unit (NICU). , 2014, Journal of clinical and diagnostic research : JCDR.
[86] Susanne Hopf,et al. Comparison of point-of-care testing glucose results from intensive care patients measured with network-ready devices. , 2011, Diabetes technology & therapeutics.
[87] N. Sharief,et al. The inaccuracy of venous and capillary blood glucose measurement using reagent strips in the newborn period and the effect of haematocrit. , 2000, Early human development.
[88] R. DeFronzo,et al. Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.
[89] G. Freckmann,et al. Impact of partial pressure of oxygen in blood samples on the performance of systems for self-monitoring of blood glucose. , 2014, Diabetes technology & therapeutics.
[90] Scott K Aberegg,et al. Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.
[91] B. Ginsberg. Factors Affecting Blood Glucose Monitoring: Sources of Errors in Measurement , 2009, Journal of diabetes science and technology.
[92] S. N. Narla,et al. Challenges of Inpatient Blood Glucose Monitoring: Standards, Methods, and Devices to Measure Blood Glucose , 2015, Current Diabetes Reports.